These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10549956)
1. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Junor EJ; Hole DJ; McNulty L; Mason M; Young J Br J Obstet Gynaecol; 1999 Nov; 106(11):1130-6. PubMed ID: 10549956 [TBL] [Abstract][Full Text] [Related]
2. Management of ovarian cancer: referral to a multidisciplinary team matters. Junor EJ; Hole DJ; Gillis CR Br J Cancer; 1994 Aug; 70(2):363-70. PubMed ID: 8054286 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery for stage IV epithelial ovarian cancer. Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968 [TBL] [Abstract][Full Text] [Related]
4. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. Gillis CR; Hole DJ BMJ; 1996 Jan; 312(7024):145-8. PubMed ID: 8563532 [TBL] [Abstract][Full Text] [Related]
5. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Kehoe S; Powell J; Wilson S; Woodman C Br J Cancer; 1994 Nov; 70(5):1014-7. PubMed ID: 7947077 [TBL] [Abstract][Full Text] [Related]
6. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer: patterns of care in Victoria during 1993-1995. Grossi M; Quinn MA; Thursfield VJ; Francis PA; Rome RM; Planner RS; Giles GG Med J Aust; 2002 Jul; 177(1):11-6. PubMed ID: 12088472 [TBL] [Abstract][Full Text] [Related]
8. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985 [TBL] [Abstract][Full Text] [Related]
9. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677 [TBL] [Abstract][Full Text] [Related]
10. National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England. Shaw M; Wolfe C; Raju KS; Papadopoulos A Eur J Gynaecol Oncol; 2003; 24(3-4):246-50. PubMed ID: 12807233 [TBL] [Abstract][Full Text] [Related]
12. Advanced epithelial ovarian carcinoma: long-term survival experience at the community hospital. Unzelman RF Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 1):1663-71; discussion 1671-2. PubMed ID: 1615973 [TBL] [Abstract][Full Text] [Related]
13. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer? Woodman C; Baghdady A; Collins S; Clyma JA Br J Obstet Gynaecol; 1997 Feb; 104(2):135-9. PubMed ID: 9070126 [TBL] [Abstract][Full Text] [Related]
14. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275 [TBL] [Abstract][Full Text] [Related]
16. Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group). Wimberger P; Wehling M; Lehmann N; Kimmig R; Schmalfeldt B; Burges A; Harter P; Pfisterer J; du Bois A Ann Surg Oncol; 2010 Jun; 17(6):1642-8. PubMed ID: 20165986 [TBL] [Abstract][Full Text] [Related]
17. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up. Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J; Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women. Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354 [TBL] [Abstract][Full Text] [Related]
19. Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals. Paulsen T; Kjaerheim K; Kaern J; Tretli S; Tropé C Int J Gynecol Cancer; 2006; 16 Suppl 1():11-7. PubMed ID: 16515561 [TBL] [Abstract][Full Text] [Related]
20. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis. Rauh-Hain JA; Gonzalez R; Bregar AJ; Clemmer J; Hernández-Blanquisett A; Clark RM; Schorge JO; Del Carmen MG Gynecol Oncol; 2016 Jul; 142(1):38-43. PubMed ID: 27107722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]